ID: ALA3961578

Max Phase: Preclinical

Molecular Formula: C19H16N4O3

Molecular Weight: 348.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(c1ccccc1)n1cc(C(=O)/C=C/c2ccc([N+](=O)[O-])cc2)nn1

Standard InChI:  InChI=1S/C19H16N4O3/c1-14(16-5-3-2-4-6-16)22-13-18(20-21-22)19(24)12-9-15-7-10-17(11-8-15)23(25)26/h2-14H,1H3/b12-9+

Standard InChI Key:  VKTNCUUHHUSGOY-FMIVXFBMSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 348.36Molecular Weight (Monoisotopic): 348.1222AlogP: 3.69#Rotatable Bonds: 6
Polar Surface Area: 90.92Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.40CX LogD: 4.40
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.29Np Likeness Score: -1.03

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):